EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Metabolic syndrome: pathophysiology, management, and modulation by natural compounds

Yogita Rochlani, Naga Venkata Pothineni, Swathi Kovelamudi, Jawahar L Mehta

Therapeutic Advances in Cardiovascular Disease · 2017-08 · 11 (8) · 215-225

DOI: 10.1177/1753944717711379 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Cardiovascular Disease, online erschienen am 22.06.2017. Verfasst von Yogita Rochlani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Westchester Medical Center, Valhalla, NY, USA. Hauptthemen laut MEDLINE: Dietary Supplements. Die Arbeit wurde bisher 903-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic syndrome (MetS) represents a cluster of metabolic abnormalities that include hypertension, central obesity, insulin resistance, and atherogenic dyslipidemia, and is strongly associated with an increased risk for developing diabetes and atherosclerotic and nonatherosclerotic cardiovascular disease (CVD). The pathogenesis of MetS involves both genetic and acquired factors that contribute to the final pathway of inflammation that leads to CVD. MetS has gained significant importance recently due to the exponential increase in obesity worldwide. Early diagnosis is important in order to employ lifestyle and risk factor modification. Here, we review the epidemiology and pathogenesis of MetS, the role of inflammation in MetS, and summarize existing natural therapies for MetS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary SupplementsAnti-Inflammatory AgentsEarly DiagnosisHumansInflammationMetabolic SyndromePredictive Value of TestsRisk FactorsTreatment Outcome

Stichwörter der Autor:innen

atherogenic dyslipidemiacardiovascular diseasehypertensioninsulin resistancemetabolic syndromenutraceuticalsobesity

Substanzen

Anti-Inflammatory Agents

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Westchester Medical Center, Valhalla, NY, USA.
  • Division of Cardiovascular Medicine, Central Arkansas Veterans Healthcare System and University of Arkansas for Medical Sciences, 4301 W. Markham St. #532, Little Rock, AR 72205, USA.
  • Division of Cardiovascular Medicine, Central Arkansas Veterans Healthcare System and University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Zitieren

APA

Rochlani, Y., Pothineni, N. V., Kovelamudi, S., & Mehta, J. L. (2017). Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Therapeutic Advances in Cardiovascular Disease, 11(8), 215-225. https://doi.org/10.1177/1753944717711379

Vancouver

Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Therapeutic Advances in Cardiovascular Disease. 2017;11(8):215-225. doi:10.1177/1753944717711379

BibTeX
@article{Rochlani2017,
  author = {Rochlani, Yogita and Pothineni, Naga Venkata and Kovelamudi, Swathi and Mehta, Jawahar L},
  title = {Metabolic syndrome: pathophysiology, management, and modulation by natural compounds},
  journal = {Therapeutic Advances in Cardiovascular Disease},
  year = {2017},
  volume = {11},
  number = {8},
  pages = {215--225},
  doi = {10.1177/1753944717711379}
}
Kostenlos starten →